These results demonstrated that with CD20, genes encoding CD74 and IL4R are highly expressed in lymphoma tissues, in addition to being broad B cell markers, and could represent candidate therapeutic targets for lymphoma. The gene discussed is MS4A1; the disease is lymphoma.